Lv4
510 积分 2024-12-04 加入
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2小时前
待确认
Exploiting temporal aspects of cancer immunotherapy
2小时前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
12天前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
12天前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
12天前
已完结
皖公网安备34019202002308
